Abstract
The association between Sjögren’s syndrome (SS) and protein-losing enteropathy (PLE) was scarcly reported. To analyze the clinical, therapeutic, and outcome characteristics of patients with SS and PLE and also to delineate the potential mechanisms and pathways connecting the gut to SS targeted organ’s pathology. Systematic screening was conducted using PubMed/MEDLINE, LILACS, SciELO, Web of Science, and Cochrane, dating 1980 to 2020. SS and PLE were the key words. Eighteen patients with SS and PLE were summarized. The patient’s ages ranged between 20 and 88 years, and only 4 were males. Primary SS was observed in most cases. Anti-Ro was detected in 100% of the cases while anti-La was reported in 64% of them. The clinical manifestations were protein loss, edema of the lower limbs, pleural effusion, ascites, facial edema, anasarca, diarrhea, and weight loss. Among these clinical manifestations, edema of the lower limbs was the most severe. Albumin concentration was 0.9–3.4 g/dL which increased to 2.8–4.3 g/dL after treatment. Small bowel biopsy was performed in all of the cases. Concerning the therapy, all the patients received systemic glucocorticoids. All of them improved. The period of onset of improvement ranged from 3 weeks to 36 months (an average of 3 months). The early diagnosis and appropriate therapy of PLE in patients with anti-Ro positive SS and who present edema, anasarca, or hypoalbuminemia is vital for a beneficial outcome. An excellent clinical improvement in all the cases was observed when treated early enough by cortico-therapy, thus preventing patient’s deterioration, complications, and reducing morbidity and potential mortality.
Similar content being viewed by others
References
Thorne I, Sutcliffe N (2017) Sjögren’s syndrome. Br J Hosp Med (Lond) 78:438–442
Shahane A, Patel R (2014) The epidemiology of Sjögren’s syndrome. Clin Epidemiol 6:247
Ramos-Casals M, Brito-Zerón P, Si Só-Almirall A, Bosch X (2012) Primary Sjögren syndrome. BMJ 344:e3821
Mavragani CP, Moutsopoulos HM (2014) Sjögren syndrome. CMAJ 186:E579–E586
Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE (2019) Gastrointestinal manifestations of rheumatological diseases. Am J Gastroenterol 114:1441–1454
Tsutsumi A, Sugiyama T, Matsumura R, Sueishi M, Takabayashi K, Koike T, Tomioka H, Yoshida S (1991) Protein-losing enteropathy associated with collagen diseases. Ann Rheum Dis 50:178–181
Mavragani CP, Moutsopoulos HM (2019) Primary versus secondary Sjögren syndrome: is it time to reconsider these terms? J Rheumatol 46:665–666
Umar SB, Dibiase JK (2010) Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol 105:43–49
Levitt D, Levitt M (2017) Protein-losing enteropathy: a comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol 10:147–168
Liao C-Y, Chien S-T, Wang C-C, Chen I-H, Chiu H-W, Liu M-Y, Lin CH, Ben RJ, Tsai MK (2015) Sjögren’s syndrome associated with protein-losing gastroenteropathy manifested by intestinal lymphangiectasia successfully treated with prednisolone and hydroxychloroquine. Lupus 24:1552–1556
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheum 69:35–45
Mok MY, Lau CS (1997) Protein-losing enteropathy and primary Sjögren's syndrome. Clin Exp Rheumatol 15:705
Hsieh T-Y, Lan J-L, Chen D-Y (2002) Primary Sjögren’s syndrome with protein-losing gastroenteropathy: report of two cases. J Formos Med Assoc 101:519–541
Ushiyama A, Teraoka H, Shiba T, Saito T, Nagata J, Koike J, Mine T (2004) Protein-losing gastroenteropathy associated with Sjögren syndrome-case report and review of the Japanese literature. Nippon Shokakibyo Gakkai Zasshi 101:1314–1319
Nagashima T, Hoshino M, Shimoji S, Morino N, Kamimura T, Okazaki H, Minota S (2009) Protein-losing gastroenteropathy associated with primary Sjögren’s syndrome: a characteristic oriental variant. Rheumatol Int 29:817–820
Nasu T, Miyata K, Uno A, Kawashima A, Kondo M, Akamizu T, Nakao T (2011) Successful treatment of protein-losing gastroenteropathy with steroid pulse and immunosuppressive therapies in a patient with Sjögren syndrome. Case Rep Gastroenterol 5:372–377
Kakigao K, Fukushima N, Mizutani T, Haraguchi K, Okamoto R, Sawamura N et al (2012) A case of protein-losing gastroenteropathy accompanied by Sjögren syndrome and mixed connective tissue disease. Nihon Shokakibyo Gakkai Zasshi 109:1770–1775
Hiroyuki Y, Go M, Remi H, Haruhito S, Yuko T, Hiroshi K et al (2014) A case of Sjogren's syndrome complicated by protein-losing gastroenteropathy with unprecedented pulmonary interstitial lesions. Mod Rheumatol 24:877–879
Gupta A, Cohen NL, McCarthy S, McHugh JB, Kwon R (2015) Protein-losing gastroenteropathy associated with Sjögrenʼs syndrome: first known case reported outside of Asia. ACG Case Rep J 2:184–186
Izumi Y, Nakaoka K, Kamata M, Iwanaga N, Imadachi S, Kurohama H, Ito M, Migita K (2018) Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren’s syndrome successfully treated with mizoribine. Mod Rheumatol 28:716–720
Eguchi M, Iwanaga N, Sakai K, Michitsuji T, Tsuji Y, Kawahara C, Kobayashi H, Horai Y, Mori T, Izumi Y, Ito M, Kawakami A (2018) Protein-losing gastroenteropathy in a patient with concomitant systemic lupus erythematosus and Sjögren’s syndrome. Immunol Med 41:34–38
Watanabe K, Murakami S, Misago M, Yoshikawa M, Tamai D, Nakao S, Ueoka T, Ito M, Shinomura Y, Kajiwara N (2018) Sjögren’s syndrome concurrent with protein-losing gastroenteropathy with secondary systemic capillary leak syndrome: a case report. Clin Case Rep 6:1829–1833
Nakamura T, Shiraishi N, Morikami Y, Fujii H, Itoshima H, Kamio T (2019) Protein-losing enteropathy may be an important characteristic manifestation in Sjögren’s syndrome. Mod Rheumatol 29:397–399
Li X, Lin F, Wu Z, Chen Y, Zhu P (2019) A case report of Sjögren’s syndrome associated with protein-losing gastroenteropathy successfully treated with methylprednisolone. J Int Med Res:030006051987454. https://doi.org/10.1177/0300060519874543
Akaishi T, Yasaka K, Abe M, Fujii H, Watanabe M, Shirai T, Ishizawa K, Takayama S, Kagaya Y, Harigae H, Ishii T (2020) Protein-losing gastroenteropathy with severe hypoalbuminemia associated with Sjögren’s syndrome: a case report and review of the literature. J Gen Fam Med 21:24–28
Uraoka Y, Tanigawa T, Watanabe K, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Watanabe T, Fujiwara Y, Arakawa T (2012) Complete remission of protein-losing gastroenteropathy associated with Sjögren's syndrome by B cell-targeted therapy with rituximab. Am J Gastroenterol 107:1266–1268
Takenaka H, Ohmiya N, Hirooka Y, Nakamura M, Ohno E, Miyahara R, Kawashima H, Itoh A, Watanabe O, Ando T, Goto H (2012) Endoscopic and imaging findings in protein-losing enteropathy. J Clin Gastroenterol 46:575–580
Chen Z, Li MT, Xu D, Yang H, Li J, Zhao JL, Zhang HH, Han SM, Xu T, Zeng XF (2014) Protein-losing enteropathy in systemic lupus erythematosus: 12 years experience from a Chinese academic center. PLoS One 9:e114684. https://doi.org/10.1371/journal.pone.0114684
Haeney MR, Fields J, Carter RA, Thompson RA, Asquith P (1979) Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy? Lancet. 2:1161–1162
Lerner A, Matthias T (2016) GUT-the Trojan horse in remote organs’ autoimmunity. J Clin Cell Immunol 7:401
Lerner A, Neidhöfer S, Matthias T (2017) The gut microbiome feelings of the brain: perspective for non-microbiologists. Microorganisms. https://doi.org/10.3390/microorganisms5040066
Lerner A, Matthias T (2015) Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev 14:479–489
Nesvold MB, Jensen JL, Hove LH, Singh PB, Young A, Palm Ø, Andersen LF, Carlsen MH, Iversen PO (2018) Dietary Intake, Body composition, and oral health parameters among female patients with primary Sjögren’s syndrome doi: https://doi.org/10.3390/nu10070866
Lerner A, Aminov R, Matthias T (2016) Dysbiosis may trigger autoimmune diseases via inappropriate posttranslational modification of host proteins. Front Microbiol 7:84
Omatsu T, Omura M, Katayama Y, Kimura T, Okumura M, AOkumura A et al (2018) Molecular diversity of the faecal microbiota of toy poodles in Japan. J Vet Med Sci 80:749–754
Skopouli FN, Katsiougiannis S (2018) How stress contributes to autoimmunity-lessons from Sjögren’s syndrome. FEBS Lett 592:5–14
Bode L, Freeze HH (2006) Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim Biophys Acta 1760:547–559
Funding
The work is supported by a grant from the Government of the Russian Federation (contract 14.W03.31.0009 of 13/02/2017) for state support of scientific research conducted under the supervision of leading scientists.
Author information
Authors and Affiliations
Contributions
CG: Literature screening, case reporting, manuscript preparation.
JFC: Conceptualization, literature screening and data curation, manuscript writing.
AL: Introduction and discussion on the gut-ss axis relationships.
YS: Review, editing, and supporting.
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Carvalho, J.F., Lerner, A., Gonçalves, C.M. et al. Sjögren syndrome associated with protein-losing enteropathy: case-based review. Clin Rheumatol 40, 2491–2497 (2021). https://doi.org/10.1007/s10067-020-05487-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05487-5